+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2025-2030- Product Image
Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2025-2030- Product Image
Sale

Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337450
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Controlled Release Drug Delivery Market grew from USD 43.07 billion in 2023 to USD 46.70 billion in 2024. It is expected to continue growing at a CAGR of 9.17%, reaching USD 79.62 billion by 2030.

Controlled Release Drug Delivery (CRDD) systems are designed to deliver medications at a predetermined rate, locally or systemically, for a specified period of time. This technology enhances therapeutic efficacy, reduces side effects, and improves patient compliance by maintaining optimal drug concentration levels. CRDD is essential in treating chronic illnesses, providing prolonged therapeutic effects, and ensuring patient adherence to treatment regimens. It finds applications in various therapeutic areas, including cardiovascular diseases, diabetes, cancer, and neurological disorders. End-use scope extends to pharmaceutical and biotechnology companies, research institutions, and academic entities.

The market for CRDD is driven by factors such as increasing prevalence of chronic diseases, demand for tailored therapies, advancements in polymer and material sciences, and an emphasis on patient-centric care. The growth is further supported by technological innovations in drug delivery systems, such as nanoparticles, liposomes, and biodegradable polymers. Regulatory support and favorable reimbursement policies also play a pivotal role. However, challenges persist, including high R&D costs, stringent regulatory frameworks, potential for drug toxicity, and the need for robust clinical trials to validate efficacy and safety. Limitations also include technical constraints concerning drug formulation and potential environmental impact of delivery materials.

Opportunities in the CRDD market lie in exploring untapped regions, advancing personalized medicine, and expanding partnerships for the co-development of novel delivery technologies. Growth can be catalyzed by focusing on emerging markets, investing in nanotechnology-based delivery systems, and enhancing biocompatibility and precision of delivery devices. Businesses are recommended to invest in collaborations between academia and industry to foster innovation, and to continually monitor regulatory landscapes to align future developments accordingly. Innovations in drug delivery pathways, such as transdermal and ocular systems, and the integration of smart technology, including IoT for real-time monitoring, represent significant areas for research and market expansion. The market nature is highly dynamic, driven by continuous technological advancements and evolving patient needs, requiring businesses to remain agile and forward-thinking in their strategic approaches.

Understanding Market Dynamics in the Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
    • Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
    • Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
  • Market Restraints
    • Complex Manufacturing Process of Controlled Release Drug Delivery System
  • Market Opportunities
    • Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
    • Advances in Control Release Drug Delivery System
  • Market Challenges
    • Potential limitation of controlled drug release formulation

Exploring Porter’s Five Forces for the Controlled Release Drug Delivery Market

Porter’s Five Forces framework further strengthens the insights of the Controlled Release Drug Delivery Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Controlled Release Drug Delivery Market

External macro-environmental factors deeply influence the performance of the Controlled Release Drug Delivery Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Tandem Diabetes Care, Inc., Johnson & Johnson Services, Inc., Insulet Corporation, Merck & Co., Inc., Alkermes PLC, GlaxoSmithKline PLC, Becton, Dickinson and Company, Pensatech Pharma GmbH, Celares GmbH, Trelleborg AB, Lonza Group Ltd., Celanese Corporation, Boehringer Ingelheim International GmbH, CURE Pharmaceutical, Baxter International Inc., Medtronic PLC, Colorcon, Inc., Adare Pharma Solutions, Collegium Pharmaceutical, Inc., Pfizer Inc., Catalent, Inc., Avantor, Inc., Corium, Inc., AMW GmbH, Seqens, Biogen Inc., Coating Place, Inc., and AstraZeneca PLC.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Release Mechanism
    • Activation-Modulated Drug Delivery Systems
      • Hydrodynamic Pressure Activated
      • Magnetically Activated
      • Mechanically Activated
      • Osmotic Pressure Activated
      • Vapor Pressure Activated
    • Chemically Activated
      • Enzyme Activated
      • Hydrolysis Activated
      • pH Activated
    • Feedback Regulated Drug Delivery Systems
    • Micro Reservoir Partition Controlled Drug Delivery Systems
    • Polymer Based Systems
  • Technology
    • Coacervation
    • Implants
    • Micro Encapsulation
    • Targeted Delivery
    • Transdermal
    • Wurster Technique
  • Application
    • Drug Eluting Stents
    • Infusion Pumps
    • Injectable
    • Metered Dose Inhalers
    • Oral Controlled-Drug Delivery Systems
    • Transdermal & Ocular Patches
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
5.1.2. Restraints
5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
5.1.3. Opportunities
5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
5.1.3.2. Advances in Control Release Drug Delivery System
5.1.4. Challenges
5.1.4.1. Potential limitation of controlled drug release formulation
5.2. Market Segmentation Analysis
5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Controlled Release Drug Delivery Market, by Release Mechanism
6.1. Introduction
6.2. Activation-Modulated Drug Delivery Systems
6.2.1. Hydrodynamic Pressure Activated
6.2.2. Magnetically Activated
6.2.3. Mechanically Activated
6.2.4. Osmotic Pressure Activated
6.2.5. Vapor Pressure Activated
6.3. Chemically Activated
6.3.1. Enzyme Activated
6.3.2. Hydrolysis Activated
6.3.3. pH Activated
6.4. Feedback Regulated Drug Delivery Systems
6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
6.6. Polymer Based Systems
7. Controlled Release Drug Delivery Market, by Technology
7.1. Introduction
7.2. Coacervation
7.3. Implants
7.4. Micro Encapsulation
7.5. Targeted Delivery
7.6. Transdermal
7.7. Wurster Technique
8. Controlled Release Drug Delivery Market, by Application
8.1. Introduction
8.2. Drug Eluting Stents
8.3. Infusion Pumps
8.4. Injectable
8.5. Metered Dose Inhalers
8.6. Oral Controlled-Drug Delivery Systems
8.7. Transdermal & Ocular Patches
9. Americas Controlled Release Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Controlled Release Drug Delivery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Controlled Release Drug Delivery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery
List of Figures
FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 54. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 56. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 81. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 82. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 83. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 86. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 87. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 88. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 96. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 111. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 116. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 118. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 121. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 122. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 123. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 126. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 128. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 131. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 133. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 142. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 144. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 147. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 149. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 152. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 154. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 159. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 162. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 164. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 167. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 169. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 172. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 174. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 187. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 188. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 189. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 192. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 194. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 197. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 199. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 217. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 219. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 234. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 247. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Controlled Release Drug Delivery market, which are profiled in this report, include:
  • Tandem Diabetes Care, Inc.
  • Johnson & Johnson Services, Inc.
  • Insulet Corporation
  • Merck & Co., Inc.
  • Alkermes PLC
  • GlaxoSmithKline PLC
  • Becton, Dickinson and Company
  • Pensatech Pharma GmbH
  • Celares GmbH
  • Trelleborg AB
  • Lonza Group Ltd.
  • Celanese Corporation
  • Boehringer Ingelheim International GmbH
  • CURE Pharmaceutical
  • Baxter International Inc.
  • Medtronic PLC
  • Colorcon, Inc.
  • Adare Pharma Solutions
  • Collegium Pharmaceutical, Inc.
  • Pfizer Inc.
  • Catalent, Inc.
  • Avantor, Inc.
  • Corium, Inc.
  • AMW GmbH
  • Seqens
  • Biogen Inc.
  • Coating Place, Inc.
  • AstraZeneca PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 46.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.62 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Controlled Release Drug Delivery Market Report and Forecast 2024-2032 - Product Image

Controlled Release Drug Delivery Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Controlled Release Drug Delivery Global Market Report 2024 - Product Image

Controlled Release Drug Delivery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
Controlled Release Drug Delivery Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Controlled Release Drug Delivery Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 105 Pages
  • Global
From

About the Controlled Drug Delivery Market

The Controlled Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the development and delivery of drugs to patients. Controlled Drug Delivery is a type of drug delivery system that allows for the precise and controlled release of drugs over a predetermined period of time. This type of drug delivery system is beneficial for patients who require a steady and consistent dose of medication over a long period of time. It also helps to reduce the risk of side effects and drug interactions. The Controlled Drug Delivery market is composed of a variety of companies that specialize in the development and delivery of controlled drug delivery systems. These companies include Novartis, Pfizer, Merck, Sanofi, and Johnson & Johnson. Additionally, there are a number of smaller companies that specialize in the development of drug delivery systems, such as AptarGroup, 3M, and West Pharmaceutical Services. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.